BPMC News and Press, Blueprint Medicines Corporation From 07/08/24

A look at the top 10 most actives in the United States Maxeon Solar Technologies Ltd. (MAXN) rose 35.3% to $0.3248 on volume of 164,333,109 shares SRIVARU Holding Limited (SVMH) rose 62.4% to $0.2581 on volume of 68,213,933 shares NVIDIA Corporation (NVDA) rose 2.9% to $129.43 on volume o...

2024-07-08 00:00:03 ET Oppenheimer analyst issues OUTPERFORM recommendation for BPMC on July 7, 2024 08:06PM ET. The previous analyst recommendation was Outperform. BPMC was trading at $111.7 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...

2024-06-10 07:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Blueprint Medicines Announces Data Presentations at EAACI and EHA Annual Meetings Highlighting Sustained Clinical Benefits of AYVAKIT®/AYVAKYT® (avapritinib) PR Newswire -- Breadth of data across 7 presentations, including 4 oral, reflects continued leadership in adv...

2024-05-25 10:24:03 ET More on AbbVie, Amgen, etc. Bristol Myers Squibb: 5.5% Yielder Has Been Crushed In What Could Be A Generational Buying Opportunity Why Gilead Sciences' 4.6% Yield Doesn't Make The Cut For Smart Investors Amgen Stock: Poised To Break Out (Techni...

Blueprint Medicines to Present the First Promising and Most Advanced Clinical Data for a CDK2 Inhibitor in Combination with an Approved CDK4/6 Inhibitor in HR+/HER2- Breast Cancer at the 2024 ASCO Annual Meeting PR Newswire -- Updated Phase 1 dose escalation data show that BLU...

WILMINGTON, Del., May 20, 2024 (GLOBE NEWSWIRE) -- The law firm of Andrews & Springer LLC , a boutique securities class action law firm focused on representing shareholders, is investigating potential securities violations and breach of fiduciary duty claims against Blueprint Medicin...

2024-05-19 15:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-05-14 13:35:41 ET More on Blueprint Medicines Blueprint Medicines: Rampant Growth Mostly Priced In Blueprint Medicines Corporation (BPMC) Q1 2024 Earnings Call Transcript Blueprint Medicines Corporation 2024 Q1 - Results - Earnings Call Presentation Blue...

2024-05-13 18:15:03 ET Stephens analyst issues OVERWEIGHT recommendation for BPMC on May 13, 2024 04:31PM ET. BPMC was trading at $108.05 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 6 - Buy, 3 - Hold ...